Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients - Zhang, Yan; Cao, Wei; Jiang, Wei; Xiao, Meng; Li, Yongzhe; Tang, Ning; Liu, Zhengyin; Yan, Xiaowei; Zhao, Yongqiang; Li, Taisheng; Zhu, Tienan (Journal of thrombosis and thrombolysis, 2020)
Keywords: Aged; Antibodies, Antiphospholipid - blood; Antithrombin Proteins - analysis; Betacoronavirus - pathogenicity; Biomarkers - blood; Blood Coagulation; Blood Coagulation Factor Inhibitors - blood; Blood Coagulation Factors - analysis; Cardiology; China; Coronavirus Infections - blood; Coronavirus Infections - diagnosis; Coronavirus Infections - virology; COVID-19; Critical Illness; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products - analysis; Hematology; Host-Pathogen Interactions; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Pandemics; Pneumonia, Viral - blood; Pneumonia, Viral - diagnosis; Pneumonia, Viral - virology; Protein C - analysis; Protein S - analysis; Risk Factors; SARS-CoV-2; Thrombosis - blood; Thrombosis - diagnosis; Thrombosis - virology; China; COVID-19; Critical; Antiphospholipid antibody; Coagulopathy; Factor VIII